Dentsply and Sirona joined forces in 2016, to become the world’s largest manufacturer of professional dental solutions. Our trusted brands have empowered dental professionals, in both practices and laboratories, to provide better, safer, and faster care in all dental disciplines for over 100 years. Now, working together under one brand globally, we are dedicated to continuing this journey for many years to come. Together we have unmatched scale and resources and are committed to using them to continue driving innovation and helping dental professionals achieve more than ever before.

At Dentsply Sirona, we work with them to envision what‘s possible, then provide innovative solutions to achieve it. Education and support help move each procedure forward, ensuring the benefits of our innovations are realized. Everything we do is about helping dental professionals deliver the best possible dental care, for the benefit of their patients and practices – today and for years to come.

As The Dental Solutions Company™, Dentsply Sirona provides dental professionals a comprehensive end-to-end solutions offering. This offering includes some of the best-known and established brands in the industry. We develop, manufacture and market a complete line of dental and oral health products, including general dental supplies and devices, CAD/CAM restoration systems (CEREC and inLab), a full suite of dental restorative products, digital intra-oral, panoramic and 3D imaging systems, dental treatment centers, handpieces, hygiene systems, and dental specialty products in orthodontics, endodontics and implants. Additionally, our global consumable healthcare product team provides innovative urological and surgical solutions designed to improve quality of life for patients. We are proud to be a preferred partner for dental practices, clinics, dental laboratories and authorized distributors worldwide.

Dentsply Sirona’s Global Headquarters is located in York, Pennsylvania, and the International Headquarters is based in Salzburg, Austria. Our shares are listed in the United States on NASDAQ under the symbol XRAY, and in the 12 months ended December 31, 2015, the combined company had pro-forma revenue of approximately $4 billion.